Acumen Pharmaceuticals, Inc. SEC filings
Every EDGAR filing for Acumen Pharmaceuticals, Inc. (ABOS), newest first, with AI summaries and stories.
- Ticker
- ABOS
- CIK
- 1576885
- Latest filing
- Sep 16
Next: earnings expected ~Nov 12 · 10-Q expected ~Nov 12 (deadline Nov 16)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KAcumen Pharmaceuticals, Inc.ABOSLIVE ROUTINES-8Acumen Pharmaceuticals, Inc.ABOSLIVE NOTABLE10-QAcumen Pharmaceuticals, Inc.ABOSLIVE ROUTINE8-KAcumen Pharmaceuticals, Inc.ABOSLIVE ROUTINE4Acumen Pharmaceuticals, Inc.ABOSLIVE Derrell Porter, insider filing for ABOS
Derrell Porter, reporting
ROUTINE144Acumen Pharmaceuticals, Inc.ABOSLIVE Derrell Porter, planned sale of ABOS shares
Derrell Porter, reporting
ROUTINE144Acumen Pharmaceuticals, Inc.ABOSLIVE Derrell Porter, planned sale of ABOS shares
Derrell Porter, reporting
ROUTINE8-KAcumen Pharmaceuticals, Inc.ABOSLIVE ROUTINE144Acumen Pharmaceuticals, Inc.ABOSLIVE Derrell Porter, planned sale of ABOS shares
Derrell Porter, reporting
ROUTINE4Acumen Pharmaceuticals, Inc.ABOSLIVE Nathan B Fountain, insider filing for ABOS
Nathan B Fountain, reporting
ROUTINE144Acumen Pharmaceuticals, Inc.ABOSLIVE Nathan B Fountain, planned sale of ABOS shares
Nathan B Fountain, reporting
ROUTINE4Acumen Pharmaceuticals, Inc.ABOSLIVE 8 insider filings
RA Capital Healthcare Fund LP, insider filing for ABOS
Show all 8
- 4Insider filing for ABOS
- 4Insider filing for ABOS
- 4Insider filing for ABOS
- 4Insider filing for ABOS
- 4Insider filing for ABOS
- 4Insider filing for ABOS
- 4Insider filing for ABOS
- 4Insider filing for ABOS
RA Capital Healthcare Fund LP, reporting · RA CAPITAL MANAGEMENT, L.P., reporting · +3 more
ROUTINE8-KAcumen Pharmaceuticals, Inc.ABOSLIVE NOTABLE10-QAcumen Pharmaceuticals, Inc.ABOSLIVE ROUTINE8-KAcumen Pharmaceuticals, Inc.ABOSLIVE ROUTINEARSAcumen Pharmaceuticals, Inc.ABOSLIVE ROUTINEDEFA14AAcumen Pharmaceuticals, Inc.ABOSLIVE ROUTINEDEF 14AAcumen Pharmaceuticals, Inc.ABOSLIVE ROUTINESCHEDULE 13GAcumen Pharmaceuticals, Inc.ABOSLIVE Ownership stake disclosure by James B Murray Jr
James B Murray Jr, filed by
ROUTINEEFFECTAcumen Pharmaceuticals, Inc.ABOSLIVE ROUTINE424B3Acumen Pharmaceuticals, Inc.ABOSLIVE ROUTINES-3Acumen Pharmaceuticals, Inc.ABOSLIVE ROUTINES-8Acumen Pharmaceuticals, Inc.ABOSLIVE NOTABLE10-KAcumen Pharmaceuticals, Inc.ABOSLIVE ROUTINE8-KAcumen Pharmaceuticals, Inc.ABOSLIVE ROUTINE4Acumen Pharmaceuticals, Inc.ABOSLIVE RA Capital Healthcare Fund LP, insider filing for ABOS
RA Capital Healthcare Fund LP, reporting · RA CAPITAL MANAGEMENT, L.P., reporting · +3 more
NOTABLESCHEDULE 13D/AAcumen Pharmaceuticals, Inc.ABOSLIVE Ownership stake disclosure by RA CAPITAL MANAGEMENT, L.P. (amended)
RA CAPITAL MANAGEMENT, L.P., filed by
ROUTINE8-KAcumen Pharmaceuticals, Inc.ABOSLIVE ROUTINE4Acumen Pharmaceuticals, Inc.ABOSLIVE Derek M Meisner, insider filing for ABOS
Derek M Meisner, reporting
ROUTINE144Acumen Pharmaceuticals, Inc.ABOSLIVE Derek M Meisner, planned sale of ABOS shares
Derek M Meisner, reporting
ROUTINE4Acumen Pharmaceuticals, Inc.ABOSLIVE Derek M Meisner, insider filing for ABOS
Derek M Meisner, reporting
ROUTINE144Acumen Pharmaceuticals, Inc.ABOSLIVE Derek M Meisner, planned sale of ABOS shares
Derek M Meisner, reporting
ROUTINE4Acumen Pharmaceuticals, Inc.ABOSLIVE Derek M Meisner, insider filing for ABOS
Derek M Meisner, reporting
ROUTINE144Acumen Pharmaceuticals, Inc.ABOSLIVE Derek M Meisner, planned sale of ABOS shares
Derek M Meisner, reporting
ROUTINE144Acumen Pharmaceuticals, Inc.ABOSLIVE Derek M Meisner, planned sale of ABOS shares
Derek M Meisner, reporting
ROUTINE4Acumen Pharmaceuticals, Inc.ABOSLIVE 5 insider filings
Derek M Meisner, insider filing for ABOS
Show all 5
- 4Insider filing for ABOS
- 4Insider filing for ABOS
- 4Insider filing for ABOS
- 4Insider filing for ABOS
- 4Insider filing for ABOS
Derek M Meisner, reporting
ROUTINE144Acumen Pharmaceuticals, Inc.ABOSLIVE Derek M Meisner, planned sale of ABOS shares
Derek M Meisner, reporting
ROUTINE144Acumen Pharmaceuticals, Inc.ABOSLIVE 2 Form 144 notices
Derek M Meisner, planned sale of ABOS shares
Show all 2
- 144Planned insider sale of ABOS shares
- 144Planned insider sale of ABOS shares
Derek M Meisner, reporting